Receive The Newest Study Notifications

Zymeworks Announces Agreement with Pfizer and Initiation of a New Phase 2 Trial Evaluating ZW25 in Combination with Ibrance® (palbociclib)

by Lance Smith | Jan 13, 2020 | Study Scavenger Clinical Trial Recruitment Platform

Potential for a Novel Chemotherapy-Free Treatment Option for People with Advanced HER2-positive, HR-positive Breast Cancer VANCOUVER, British Columbia–(BUSINESS WIRE)–Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing...

Positive Final 2-Year Topline Data in Completed DC Vaccine Phase I/II trial in AML Patients

by Lance Smith | Jan 13, 2020 | Study Scavenger Clinical Trial Recruitment Platform

MARTINSRIED, Germany and MUNICH, Germany, Jan. 10, 2020 (GLOBE NEWSWIRE) — Medigene AG (Medigene, FSE: MDG1, Prime Standard), a clinical stage immuno-oncology company focusing on the development of T cell immunotherapies, today publishes topline results from its...

Adverum Biotechnologies Reports Continued Momentum with OPTIC Trial for ADVM-022 Intravitreal Gene Therapy in Wet AMD and Provides 2020 Outlook

by Lance Smith | Jan 13, 2020 | Study Scavenger Clinical Trial Recruitment Platform

— OPTIC phase 1 trial progressing with plans to complete patient dosing in cohort three, begin enrollment in cohort four in 1Q20 — — IND application planned for ADVM-022 in diabetic retinopathy in 1H20; Patient enrollment targeted for 2H20 —...

Zai Lab and Novocure Announce First Patient Enrolled in a Phase 2 Pilot Trial of Tumor Treating Fields Together with Chemotherapy as First-Line Treatment of Gastric Cancer

by Lance Smith | Jan 10, 2020 | Study Scavenger Clinical Trial Recruitment Platform

Zai Lab Limited (NASDAQ: ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, and Novocure (NASDAQ: NVCR), a global oncology company with a proprietary platform technology called Tumor Treating Fields, today announced that the first...

Alucent Biomedical announces FDA approval to proceed with natural vascular scaffolding clinical trial

by Lance Smith | Jan 10, 2020 | Study Scavenger Clinical Trial Recruitment Platform

Alucent Biomedical has received US Food and Drug Administration (FDA) approval to proceed with a phase 1 clinical trial to evaluate the safety and efficacy of its Natural Vascular Scaffolding (NVS) technology. The therapy is designed to treat peripheral arterial...

Akcea and Ionis Announce Initiation of CARDIO-TTRansform Phase 3 Clinical Trial for AKCEA-TTR-LRx in Patients with TTR-mediated Amyloid Cardiomyopathy

by Lance Smith | Jan 10, 2020 | Study Scavenger Clinical Trial Recruitment Platform

BOSTON and CARLSBAD, Calif., Jan. 10, 2020 (GLOBE NEWSWIRE) — Akcea Therapeutics, Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), announced today the initiation of the...